Quality of Life in Patients Undergoing Total Pelvic Exenteration

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 12, 2024

Study Completion Date

December 12, 2024

Conditions
Total ExenterationAnterior or Posterior Pelvic ExenterationGynecologic MalignanciesColorectal MalignanciesUrologic Malignancies
Interventions
BEHAVIORAL

questionnaires/interviews

All patients who agree to participate will be interviewed for a baseline quality of life assessment prior to surgery. A brief in hospital interview will follow in the peri-operative period. In the ensuing months, patients will be interviewed at approximately 3, 6 and 12 months post-operatively (eg: 3 month interview will be done between 8-16 weeks and 6 month interview between 20-28 months post-operatively). Annual interviews in years two through five will be employed to determine areas for future study and solicit narrative on transition toward cancer survivorship.

Trial Locations (8)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11553

Memorial Sloan Kettering Nassau, Uniondale

11725

Memorial Sloan Kettering Cancer Center @ Commack, Commack

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Unknown

Memorial Sloan Kettering Basking Ridge, Basking Ridge

07748

Memorial Sloan Kettering Monmouth, Middletown

07645

Memorial Sloan Kettering Bergen, Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00597805 - Quality of Life in Patients Undergoing Total Pelvic Exenteration | Biotech Hunter | Biotech Hunter